Evaluation of content on EQ-5D as compared to disease-specific utility measures

被引:26
|
作者
Lin, Fang-Ju [1 ,2 ]
Longworth, Louise [3 ]
Pickard, A. Simon [1 ,2 ]
机构
[1] Univ Illinois, Ctr Pharmacoecon Res, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Pharm Practice & Pharm Adm, Chicago, IL 60612 USA
[3] Brunel Univ, Hlth Econ Res Grp, London, England
关键词
Disease-specific measures; EQ-5D; Utility; Preferences; Mapping; QUALITY-OF-LIFE; PREFERENCE-BASED MEASURE; OUTCOME MEASURES; CANCER-THERAPY; HEALTH-STATUS; FUNCTIONAL ASSESSMENT; SINGLE INDEX; EUROPEAN ORGANIZATION; EORTC QLQ-C30; QUESTIONNAIRE;
D O I
10.1007/s11136-012-0207-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The goal of this study was to appraise the extent of unique content on disease-specific preference-based measures (DSPMs) when contrasted with the EQ-5D using published studies and to inform whether EQ-5D could be inadequate as a utility measure in its content coverage for a given disease-specific application. A structured search of published literature was performed using PubMed and EMBASE/Medline database from Jan 1, 1990 to Mar 31, 2011. Articles were eligible for inclusion if algorithms were developed to convert components from disease-specific measures into utility scores. Of 1,029 articles identified, 50 studies satisfied the inclusion criteria. The most frequent conditions where DSPMs were developed included cancer (12 studies), coronary artery disease (4 studies), osteoarthritis, rheumatoid arthritis (3 studies of each), obesity, and stroke (2 studies of each). Most studies involved mapping items or scores from disease-specific non-preference-based measures onto a preference-based measure of health such as the EQ-5D. A substantial number of DSPMs appeared to include unique content not covered by EQ-5D dimensions. Several conditions were identified as potential areas where the richness of the EQ-5D descriptive system could be enhanced. It is yet unclear whether added dimension(s) would contribute unique explained variance to a utility score. Given the resources required to rigorously develop a utility measure, the need for such measures should be carefully vetted.
引用
收藏
页码:853 / 874
页数:22
相关论文
共 50 条
  • [1] Evaluation of content on EQ-5D as compared to disease-specific utility measures
    Fang-Ju Lin
    Louise Longworth
    A. Simon Pickard
    Quality of Life Research, 2013, 22 : 853 - 874
  • [2] USE OF A DISEASE-SPECIFIC INSTRUMENT IN ECONOMIC EVALUATIONS: MAPPING WOMAC ONTO THE EQ-5D UTILITY INDEX
    Xie, F.
    Pullenayegum, E.
    Li, S. C.
    VALUE IN HEALTH, 2010, 13 (03) : A136 - A136
  • [3] Use of a Disease-Specific Instrument in Economic Evaluations: Mapping WOMAC onto the EQ-5D Utility Index
    Xie, Feng
    Pullenayegum, Eleanor M.
    Li, Shu-Chuen
    Hopkins, Robert
    Thumboo, Julian
    Lo, Ngai-Nung
    VALUE IN HEALTH, 2010, 13 (08) : 873 - 878
  • [4] Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30
    Paul F.M. Krabbe
    Lonneke Peerenboom
    Barbara S. Langenhoff
    Theo J.M. Ruers
    Quality of Life Research, 2004, 13 : 1247 - 1253
  • [5] Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30
    Krabbe, PFM
    Peerenboom, L
    Langenhoff, BS
    Ruers, TJM
    QUALITY OF LIFE RESEARCH, 2004, 13 (07) : 1247 - 1253
  • [6] Comment on the Use of Vignettes and the EQ-5D to Value Disease-Specific Health States
    Kularatna, Sanjeewa
    Whitty, Jennifer A.
    Scuffham, Paul A.
    VALUE IN HEALTH, 2012, 15 (03) : 592 - 592
  • [7] EQ-5D VERSUS DISEASE-SPECIFIC HR-QOL INSTRUMENTS - NO CONTEST?
    Ratcliffe, A. E.
    Ratcliffe, M.
    VALUE IN HEALTH, 2012, 15 (07) : A469 - A469
  • [8] A Reply to Comment on the Use of Vignettes and the EQ-5D to Value Disease-Specific Health States
    Galante, Julieta
    Augustovski, Federico
    VALUE IN HEALTH, 2012, 15 (03) : 591 - 592
  • [9] VAS EQ-5D UTILITY INDEX IN PARKINSON'S DISEASE
    Rodriguez Violante, M.
    Cervantes Arriaga, A.
    Soto Molina, H.
    Diaz Martinez, J. P.
    Pizarro Castellanos, M.
    VALUE IN HEALTH, 2014, 17 (03) : A63 - A63
  • [10] DIFFERENCES IN DISTRIBUTIONAL PROPERTIES AND RESPONSIVENESS BETWEEN A GENERIC (EQ-5D) AND DISEASE-SPECIFIC (ASUI) UTILITY INSTRUMENT IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Gunsoy, N. B.
    Cockle, S. M.
    Nelsen, L.
    Doyle, S.
    VALUE IN HEALTH, 2017, 20 (09) : A648 - A648